This inventor holds 2 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Kazuo Sugamura, Other. Active years: 1996-1999.
Company Filing History:
2 out of 1,953 
1 out of 2 
1 out of 834,453 Years Active: 1996-1999
Title: Yuka Kanayama: Innovator in Immunology
Introduction
Yuka Kanayama is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of immunology, particularly through her innovative work on interleukin-2 receptor polypeptides. With a total of 2 patents, her research has the potential to impact medical treatments for various diseases.
Latest Patents
Yuka Kanayama's latest patents include a polypeptide that specifically binds to the gamma-chain of the human interleukin-2 receptor. This polypeptide selectively inhibits the binding of the gamma-chain to the beta-chain of the same receptor. The invention has the capability to block the human interleukin-2 response, making it a valuable tool in immunosuppressant therapies. Additionally, her patents describe a method for producing this polypeptide, which can be used to prevent graft rejection after transplantation and to treat inflammatory diseases, including allergic and autoimmune disorders.
Career Highlights
Throughout her career, Yuka Kanayama has worked with notable companies such as Ajinomoto Co., Ltd. and Kazuo Sugamura. Her experience in these organizations has contributed to her expertise in the field of immunology and biotechnology.
Collaborations
Yuka has collaborated with esteemed colleagues, including Toshiro Shimamura and Junji Hamuro. These partnerships have further enriched her research and development efforts.
Conclusion
Yuka Kanayama's innovative work in the field of immunology, particularly her patents related to interleukin-2 receptor polypeptides, showcases her significant contributions to medical science. Her research holds promise for advancing treatments for various diseases and improving patient outcomes.